AB144212
Borrelidin, threonyl-tRNA synthetase inhibitor
Be the first to review this product! Submit a review
|
(1 Publication)
MW 489.6 Da, Purity >98%. Potent antiangiogenic agent (IC50 = 0.8 nM, rat aorta). Selective threonyl-tRNA synthetase inhibitor. Antibiotic agent. CDK inhibitor. Induces apoptosis in capillary tube-forming endothelial cells. Disrupts capillary tubes and inhibits their formation. Shows antiviral and antifungal effects. Shows antiangiogenic effects in vivo. .
1 Images
- Chemical Structure
Lab
Chemical Structure - Borrelidin, threonyl-tRNA synthetase inhibitor (AB144212)
2D chemical structure image of ab144212, Borrelidin, threonyl-tRNA synthetase inhibitor
Properties and storage information
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Experimental & molecular medicine 50:e424 PubMed29328069
2018
Inhibition of MUC1 biosynthesis via threonyl-tRNA synthetase suppresses pancreatic cancer cell migration.
Applications
Unspecified application
Species
Unspecified reactive species
Seung Jae Jeong,Jong Hyun Kim,Beom Jin Lim,Ina Yoon,Ji-Ae Song,Hee-Sun Moon,Doyeun Kim,Dong Ki Lee,Sunghoon Kim
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com